Symbio Pharmaceuticals Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Symbio Pharmaceuticals Ltd with three other
companies in this sector in Japan:
Medinet Co., Ltd.
sales of 1.67 billion Japanese Yen [US$14.60 million]
of which 100%
was cell processing),
(1.91 billion Japanese Yen [US$16.65 million]
of which 54%
was Cell Therapy Technology Development Busi), and
Trans Genic Inc
(1.96 billion Japanese Yen [US$17.08 million]
Symbio Pharmaceuticals Ltd reported sales of ¥1.93 billion (US$16.86 million)
December of 2015.
decrease of 1.1%
versus 2014, when the company's sales were ¥1.96 billion.